-The Hindu Business Line The media have got it wrong on price control reversal Recently, there has been a flutter in various media channels and newspapers as to how the Modi Government has reversed certain drug price control measures announced in July 2014. As a result, we are told, prices of these drugs would increase much more than pre-July levels. This was supposed to be a sequel to Modi's visit to the...
More »SEARCH RESULT
Should India permit GM foods? -Suman Sahai
-The Tribune Agbiotechnology is presented in many forms - the most common being that it will solve world hunger. To reinforce this claim, there is an interesting word play at work. Agbiotechnology is referred to as the ‘Evergreen Revolution' or the 'Gene Revolution' but never genetic engineering, which is its correct name. Both Evergreen Revolution and Gene Revolution are deliberately coined terms which attempt to link Agbiotech with the Green Revolution....
More »SC agrees on urgent hearing of drug price plea
-The Telegraph The Supreme Court today agreed to take up "as early as possible" a plea challenging a recent NDA government decision that is alleged to have paved the way for a sharp rise in the prices of life-saving drugs. Petitioner Manohar Lal Sharma, a lawyer, has demanded a CBI probe into a September 22 government order that he says frees a list of medicines from pricing control. His public interest plea alleges...
More »Cancer drug price goes up from Rs 8,000 to Rs 1.08 lakh -Iftikhar Gilani
-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...
More »New drug era -Shamnad Basheer
-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...
More »